Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$1,032.51

12.54 (1.23%)

, GOOGL

Alphabet Class A

$1,037.29

12.23 (1.19%)

05:55
04/13/18
04/13
05:55
04/13/18
05:55

Google quietly pursues Pentagon's JEDI cloud contract, Defense One reports

Google (GOOG, GOOGL) is quietly pursuing the Pentagon's giant cloud contract, fearing an employee revolt, Defense One reports. According to a senior defense official, the competition for the Joint Enterprise Defense Infrastructure, or JEDI, which is potentially worth $10B over a decade, is shaping up to be a three-way fight between Google, Amazon (AMZN) and Microsoft (MSFT), "with Oracle (ORCL) a rather distant fourth." Previous reports have suggested that Amazon is the strongest conteder for the contract, the report adds. Reference Link

GOOG

Alphabet

$1,032.51

12.54 (1.23%)

GOOGL

Alphabet Class A

$1,037.29

12.23 (1.19%)

AMZN

Amazon.com

$1,448.50

21.45 (1.50%)

MSFT

Microsoft

$93.58

1.72 (1.87%)

ORCL

Oracle

$45.88

0.27 (0.59%)

  • 16

    Apr

  • 17

    Apr

  • 23

    Apr

  • 23

    Apr

  • 26

    Apr

  • 26

    Apr

  • 09

    May

GOOG Alphabet
$1,032.51

12.54 (1.23%)

04/10/18
MSCO
04/10/18
NO CHANGE
Target $1175
MSCO
Overweight
Morgan Stanley says consensus view on Alphabet expenses seems too optimistic
Morgan Stanley analyst Brian Nowak predicts that Alphabet's Q1 EPS will miss the consensus view by 8% as he believes consensus modeling of a $2B sequential decline in operating expenses, which he notes would be the largest sequential operating expense decline in 5 years, seems too optimistic given the company's investments in the cloud, YouTube and hardware. He also believes the company's large, important strategic investments will reinforce the need for improved disclosure from Alphabet, Nowak tells investors. While he trimmed his price target on the stock to $1,175 from $1,200, Nowak is still bullish about Alphabet's long-term opportunity and he keeps an Overweight rating on the shares.
04/11/18
04/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL), Apple (AAPL), and Facebook (FB) were initiated with a Buy at Monness Crespi. 2. Caterpillar (CAT) initiated with a Buy at Buckingham. 3. JPMorgan (JPM) initiated with a Hold at HSBC. 4. eBay (EBAY) assumed with an Overweight at KeyBanc. 5. Ericsson (ERIC) initiated with a Hold at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/18
WBLR
04/11/18
NO CHANGE
WBLR
Google interest ups chances of in-flight Wi-Fi acquisition, says William Blair
"We have seen this movie before" is what William Blair analyst Louie DiPalma says after Bloomberg reported yesterday that Google (GOOG, GOOGL) is in advanced talks to acquire Nokia's in-flight connectivity hardware business. Google joins a long list of technology, telecom, and media providers that have exhibited a strategic interest in in-flight Wi-Fi, "although all have thus far stayed on the perimeter," DiPalma tells investors in a research note. The analyst notes that incumbents Gogo (GOGO), Panasonic (PCRFY), ViaSat (VSAT), Global Eagle Entertainment (ENT), and Inmarsat (IMASY) have invested billions toward satellite capacity and infrastructure. The industry is all about scale and potential new entrants would not have any, DiPalma contends. He believes it would take any new entrant many years to build a network from scratch, obtain regulatory approvals, and procure line-fit partnerships. The analyst thinks Google's interest in in-flight connectivity increases the probability that a tech or telecom company would buy an incumbent in the space. DiPalma has Outperform ratings on ViaSat and Gogo and a Market Perform rating on Global Eagle.
04/05/18
KEYB
04/05/18
NO CHANGE
KEYB
Sector Weight
Automation the next 'cloud wars' battle, says KeyBanc
KeyBanc analyst Brent Bracelin says the AWS Summit SF exposed an even greater focus by Amazon (AMZN) Web Services on cloud automation. The analyst believes the "cloud wars" in 2018 appear to be moving from a battle of "features" seen in the last two years toward a new battle of "automation." Bracelin sees Automation as having three major benefits for AWS: it can drive material cost savings, it saves developers time, and it serves as a competitive differentiator versus Microsoft Azure (MSFT) and Google Cloud (GOOG; GOOGL). Bracelin reiterates a Sector Weight rating on Amazon's shares.
GOOGL Alphabet Class A
$1,037.29

12.23 (1.19%)

04/11/18
MONN
04/11/18
INITIATION
Target $1280
MONN
Buy
Alphabet initiated with a Buy at Monness Crespi
Monness Crespi initiated Alphabet with a Buy and $1,280 price target.
AMZN Amazon.com
$1,448.50

21.45 (1.50%)

04/11/18
MONN
04/11/18
INITIATION
Target $2000
MONN
Buy
Amazon.com transferred with a Buy at Monness Crespi
Monness Crespi transferred coverage of Amazon.com with a Buy rating and $2,000 price target.
04/05/18
UBSW
04/05/18
NO CHANGE
UBSW
Amazon contract profitable for USPS, former Postmaster General tells UBS
UBS hosted an expert call with Patrick Donahoe, former Postmaster General at the USPS, given confusion around rhetoric coming out of Washington D.C. regarding Amazon's relationship with the USPS, and press reports indicating this contract expires in October 2018. On the call, Donahoe unequivocally stated that the Amazon contract is profitable for the USPS, UBS said. The firm pointed out that USPS business is primarily split into two areas, namely market-dominant products/"monopoly mail," and competitive products where Amazon would fall. By law, competitive products must cover their costs, including both operating costs associated with the service provided and an allocation of 5.5% of the USPS's institutional/fixed costs, the firm added in a research note this morning.
04/10/18
PIPR
04/10/18
NO CHANGE
Target $1650
PIPR
Overweight
Amazon mindshare down slightly in Piper's semi-annual teen survey
Piper Jaffray's semi-annual survey of over 6,000 U.S. teens showed a slight decline in Amazon (AMZN) mindshare and that Prime adoption continues across all demographics, analyst Michael Olson tells investors in a research note. Amazon mindshare decreased two percentage points versus the prior survey. At 44% mindshare, however, Amazon has nearly eight times more mindshare than its nearest competitor Nike (NKE), Olson points out. He notes the also survey indicates that the number of U.S. Prime households would be in the high-70M range and growing at a decelerating rate. The analyst reiterates an Overweight rating on Amazon shares with a $1,650 price target.
04/06/18
MKMP
04/06/18
NO CHANGE
Target $96
MKMP
Neutral
Hasbro price target lowered to $96 from $110 at MKM Partners
MKM Partners analyst Eric Handler lowered his price target on Hasbro (HAS) to $96, saying the company's earnings will see a bigger impact from the liquidation of Toys R Us than the previous forecast. The analyst also notes headwinds for the company coming from tight inventory management at mass retailers Wal-Mart (WMT) and Amazon (AMZN). Handler adds that he has broader industry concerns, but sees some mitigating product launches for Hasbro, including a new Nerf brand launch, expanded Baby Alive product lines, continued strength from Marvel, and the possible digital launch of Magic: The Gathering Arena. The analyst keeps his Neutral rating on Hasbro.
MSFT Microsoft
$93.58

1.72 (1.87%)

04/12/18
WELS
04/12/18
NO CHANGE
WELS
Outperform
Microsoft can return to mid-teens EPS, FCF growth, says Wells Fargo
Wells Fargo analyst Phil Winslow believes Microsoft can return to mid-teens EPS and free cash flow growth as the headwinds from a declining PC market in recent years and the transition to the cloud continue abate relative to the increase in recurring subscription revenue from Azure and Office 365 and as the company continues to prudently control costs. The analyst reiterates an Outperform rating on the shares.
04/12/18
FBCO
04/12/18
NO CHANGE
Target $115
FBCO
Outperform
PC shipment data supportive of bullish thesis on Microsoft, says Credit Suisse
Credit Suisse analyst Michael Nemeroff notes that both IDC and Gartner (IT) reported preliminary PC shipment data that called out strength in the commercial market. The analyst points out that IDC highlighted that PC shipments outperformed in Q1, while Gartner noted that Q1 commercial PC shipments were strong, largely driven by Windows 10 migrations that were previously postponed during 2017. Nemeroff believes these data are supportive of his bullish thesis on Microsoft (MSFT) shares, as there is a high correlation to enterprises upgrading their productivity suite platform when upgrading their OS environments, or replacing PCs. The analyst reiterates an Outperform rating and $115 price target on Microsoft shares.
04/04/18
MSCO
04/04/18
NO CHANGE
MSCO
Morgan Stanley says CIO survey good for Microsoft, Amazon, negative for Juniper
Morgan Stanley analyst Katy Huberty detailed the results of the firm's April survey of 100 U.S. and European Chief information officers, noting that it showed the most bullish growth expectation in 10 years. CIOs surveyed see rising 2018 IT budget growth expectations, increasing their cumulative growth view to 5.4% in the most recent survey from a 4.9% growth outlook in January, Huberty noted. Cloud and Security are top priorities, and the strong public cloud adoption trends favor Amazon (AMZN) and Microsoft (MSFT), according to the analyst. Meanwhile, Huberty noted that Cisco (CSCO) saw a slight tick down in purchase intentions, Juniper Networks (JNPR) continues to sees negative spend, and F5 Networks (FFIV) saw weakening purchase intentions.
ORCL Oracle
$45.88

0.27 (0.59%)

03/20/18
JMPS
03/20/18
NO CHANGE
Target $126
JMPS
Outperform
Salesforce comp plan should help motivate Q1 performance, says JMP Securities
JMP Securities analyst Patrick Walravens noted two "interesting data points" about Salesforce (CRM) he came across while conducting his due diligence on Oracle's (ORCL) quarter. Namely, he heard that Salesforce's sales compensation plan includes a bonus for deals closed by April 15, which he thinks should help motivate the sales force toward hitting targets early in Q1. Also, he understands that Brian Millham, previously President of Global Commercial Sales and then SVP of Corporate Sales, is apparently on sabbatical and Warren Wick, who was previously SVP of Enterprise Sales, was promoted to EVP in February to run the commercial business. Walravens maintains his Outperform rating and $126 price target on Salesforce shares.
03/20/18
03/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Oracle (ORCL) downgraded to Neutral from Buy at BofA/Merrill and to Hold from Buy at Stifel. 2. Huntsman (HUN) downgraded to Neutral from Buy at Nomura Instinet with analyst Aleksey Yefremov saying he believes the shares are unlikely to outperform until demand for MDI-based polyurethanes markets finds a bottom. 3. Signet Jewelers (SIG) downgraded to Neutral from Buy at BofA/Merrill with analyst Lorraine Hutchinson saying Signet lacks growth visibility near-term and lowered estimates to reflect a weak base business, credit transition issues, and a loss of EBIT from subprime credit outsourcing. 4. Dominion (D) downgraded to Neutral from Buy at BofA/Merrill with analyst Julien Dumoulin-Smith saying the latest FERC policy changes is a headwind to Dominion's dropdown desire into Dominion Midstream (DM) and could impact valuations of midstream assets. 5. Essex Property Trust (ESS) downgraded to Hold from Buy at SunTrust with analyst Michael Lewis saying the stock's recent outperformance has narrowed its discount to NAV to the smallest margin among its peers, even though its leverage and earnings growth rate are comparable to those of peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/21/18
ARGS
03/21/18
NO CHANGE
Target $61
ARGS
Buy
Oracle's soft Q4 cloud revenue view spooked the market, says Argus
Argus analyst Joseph Bonner writes that while Oracle (ORCL) posted a beat on Q3 earnings and revenue, along with a "remarkable" margin expansion, investors were spooked by lower than expected outlook for cloud revenue growth in Q4. The analyst contends that the company's key task is conversion of its blue-chip customer base to the cloud, as cloud computing becomes a standard in the next 3-5 years. Bonner adds that Oracle is also competing with "deep-pocketed" technology giants - Amazon (AMZN) Web Services, Microsoft's (MSFT) Azure, and Google (GOOG). The analyst remains positive on Oracle's prospects with a Buy rating and a $61 price target, pointing to the company's strong dividend growth, share buyback program, and below-peer valuation metrics.
04/11/18
MONN
04/11/18
INITIATION
MONN
Neutral
Oracle initiated with a Neutral at Monness Crespi
Monness Crespi initiated Oracle with a Neutral rating.

TODAY'S FREE FLY STORIES

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, ALXN

Alexion

$125.96

-0.63 (-0.50%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
The ACR and ARHP to hold annual meeting »

American College of…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

AMGN

Amgen

$201.75

-1.03 (-0.51%)

AUPH

Aurinia Pharmaceuticals

$5.56

-0.13 (-2.28%)

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

CELG

Celgene

$82.42

-0.52 (-0.63%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FLXN

Flexion

$18.96

0.33 (1.77%)

GILD

Gilead

$73.27

-0.9 (-1.21%)

GSK

GlaxoSmithKline

$40.87

1.25 (3.16%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

RARE

Ultragenyx

$63.33

-0.77 (-1.20%)

QDEL

Quidel

$64.68

-2.85 (-4.22%)

PFE

Pfizer

$44.50

0.48 (1.09%)

NVS

Novartis

$87.19

0.95 (1.10%)

MRK

Merck

$72.34

0.12 (0.17%)

MCK

McKesson

$132.36

-0.34 (-0.26%)

LLY

Eli Lilly

$111.91

-1.4 (-1.24%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SELB

Selecta Biosciences

$13.80

-1.34 (-8.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

  • 28

    Apr

  • 13

    May

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, DCPH

Deciphera

$22.22

-4.97 (-18.28%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO 2018 Congress to be…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

DCPH

Deciphera

$22.22

-4.97 (-18.28%)

TSRO

Tesaro

$41.81

-1.19 (-2.77%)

IMGN

ImmunoGen

$7.44

-0.355 (-4.56%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

CRSP

Crispr Therapeutics

$36.02

-1.18 (-3.17%)

CLVS

Clovis

$26.41

-3.54 (-11.82%)

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

LOXO

Loxo Oncology

$160.01

-7.58 (-4.52%)

RHHBY

Roche

$0.00

(0.00%)

NCNA

NuCana

$18.90

1.9 (11.18%)

CRVS

Corvus Pharmaceuticals

$8.01

-0.1 (-1.23%)

NTGN

Neon Therapeutics

$8.88

0.56 (6.73%)

NKTR

Nektar

$48.23

-1.33 (-2.68%)

EXEL

Exelixis

$16.27

-0.25 (-1.51%)

AVEO

Aveo Pharmaceuticals

$2.50

-0.03 (-1.19%)

KURA

Kura Oncology

$14.38

-1.18 (-7.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 10

    Nov

  • 26

    Nov

  • 27

    Nov

  • 24

    Dec

  • 14

    Jan

  • 28

    Apr

  • 13

    May

A

Agilent

$64.47

-1.28 (-1.95%)

, AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
American Society of Human Genetics to hold a conference »

ASHG Conference 2018 will…

A

Agilent

$64.47

-1.28 (-1.95%)

AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

RHHBY

Roche

$0.00

(0.00%)

BMRN

BioMarin

$103.31

-0.52 (-0.50%)

BIO

Bio-Rad

$280.96

-3.23 (-1.14%)

MSFT

Microsoft

$108.55

0.01 (0.01%)

ILMN

Illumina

$313.31

-7.98 (-2.48%)

FLDM

Fluidigm

$7.49

-0.45 (-5.67%)

HZNP

Horizon Pharma

$19.07

-0.01 (-0.05%)

NVTA

Invitae

$12.86

-0.23 (-1.76%)

NSTG

NanoString

$15.18

-0.41 (-2.63%)

QGEN

Qiagen

$35.91

0.455 (1.28%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

RTRX

Retrophin

$25.34

0.24 (0.96%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

ARQL

ArQule

$4.33

-0.38 (-8.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 21

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 27

    Nov

  • 28

    Nov

  • 24

    Dec

  • 18

    Feb

  • 03

    Mar

CLBR

Caliburn International

$0.00

(0.00%)

18:27
10/19/18
10/19
18:27
10/19/18
18:27
Syndicate
Caliburn International files registration statement for proposed IPO »

Caliburn International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

18:10
10/19/18
10/19
18:10
10/19/18
18:10
General news
Saudi Arabia says Kashoggi killed after fight broke out in consulate, CNBC says 

Reference Link

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$99.62

2.61 (2.69%)

18:02
10/19/18
10/19
18:02
10/19/18
18:02
Hot Stocks
Celanese raises prices on MIBK, MIBC by EUR120/MT in Europe »

Celanese announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

REGN

Regeneron

$389.94

-5.45 (-1.38%)

, SNY

Sanofi

$44.57

0.12 (0.27%)

17:57
10/19/18
10/19
17:57
10/19/18
17:57
Hot Stocks
Regeneron, Sanofi: FDA approves asthma indication for Dupixent »

Regeneron Pharmaceuticals…

REGN

Regeneron

$389.94

-5.45 (-1.38%)

SNY

Sanofi

$44.57

0.12 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

, XLU

Utilities SPDR

$54.57

0.82 (1.53%)

17:55
10/19/18
10/19
17:55
10/19/18
17:55
General news
Week ending ETF Scorecard: Staples, Real Estate, Utilities lead rebound »

S&P500 SECTORS: …

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

XLU

Utilities SPDR

$54.57

0.82 (1.53%)

IYR

DJ US Real Estate Index Fund

$77.83

0.63 (0.82%)

XLP

Consumer Staples Sector SPDR

$54.72

1.225 (2.29%)

XLY

Consumer Discretionary Sector SPDR

$106.34

-1.06 (-0.99%)

XLB

S&P Select Materials SPDR

$53.13

-0.36 (-0.67%)

XLF

Financial Select Sector

$26.66

0.08 (0.30%)

XLV

Health Care Select Sector SPDR

$91.48

-0.93 (-1.01%)

XLK

Technology Select Sector SPDR

$70.00

-0.04 (-0.06%)

XLI

Industrial Select Sector SPDR

$73.17

-0.31 (-0.42%)

GLD

SPDR Gold Trust

$116.01

0.11 (0.09%)

SLV

iShares Silver Trust

$13.74

0.05 (0.37%)

USO

United States Oil Fund

$14.72

0.155 (1.06%)

UNG

United States Natural Gas Fund

$26.81

0.19 (0.71%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$84.90

0.04 (0.05%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.69

-0.15 (-0.13%)

TLT

iShares 20+ Year Treasury Bond Fund

$113.73

-0.24 (-0.21%)

IEF

iShares 7-10 Year Treasury Bond ETF

$100.12

-0.12 (-0.12%)

SHY

iShares 1-3 Year Treasury Bond

$82.95

-0.035 (-0.04%)

IWD

iShares Russell 1000 Value

$122.17

0.08 (0.07%)

IWF

iShares Russell 1000 Growth

$145.19

-0.5 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSW

International Seaways

$21.51

0.41 (1.94%)

17:53
10/19/18
10/19
17:53
10/19/18
17:53
Syndicate
Breaking Syndicate news story on International Seaways »

International Seaways…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$15.49

0.08 (0.52%)

17:48
10/19/18
10/19
17:48
10/19/18
17:48
Hot Stocks
Monmouth Real Estate acquires industrial building in New Jersey for $85.25M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

TEUM

Pareteum

$2.47

-0.07 (-2.76%)

17:38
10/19/18
10/19
17:38
10/19/18
17:38
Syndicate
Breaking Syndicate news story on Pareteum »

Pareteum files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

TEUM

Pareteum

$2.47

-0.07 (-2.76%)

17:36
10/19/18
10/19
17:36
10/19/18
17:36
Syndicate
Breaking Syndicate news story on Pareteum »

Pareteum files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

, LMT

Lockheed Martin

$328.22

0.21 (0.06%)

17:33
10/19/18
10/19
17:33
10/19/18
17:33
Periodicals
Trump to meet CEOs of Boeing, Lockheed Martin, General Dynamics, Reuters reports »

President Donald Trump…

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

LMT

Lockheed Martin

$328.22

0.21 (0.06%)

BA

Boeing

$356.28

-3 (-0.84%)

GD

General Dynamics

$190.43

-0.76 (-0.40%)

BAESY

BAE Systems

$0.00

(0.00%)

HON

Honeywell

$153.49

-1.73 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 30

    Oct

ISR

IsoRay

$0.50

0.0191 (3.98%)

17:25
10/19/18
10/19
17:25
10/19/18
17:25
Syndicate
Breaking Syndicate news story on IsoRay »

IsoRay files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHS

Neuberger Berman High Yield Strategies Fd

$10.55

-0.015 (-0.14%)

17:06
10/19/18
10/19
17:06
10/19/18
17:06
Hot Stocks
Breaking Hot Stocks news story on Neuberger Berman High Yield Strategies Fd »

Saba Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOC

Biocept

$2.27

-0.04 (-1.73%)

17:04
10/19/18
10/19
17:04
10/19/18
17:04
Syndicate
Breaking Syndicate news story on Biocept »

Biocept files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$726.10

-4.09 (-0.56%)

17:03
10/19/18
10/19
17:03
10/19/18
17:03
Hot Stocks
AutoZone founder Hyde will not stand for board re-election »

AutoZone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SACH

Sachem Capital

$4.33

0.02 (0.46%)

17:03
10/19/18
10/19
17:03
10/19/18
17:03
Syndicate
Breaking Syndicate news story on Sachem Capital »

Sachem Capital files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

16:53
10/19/18
10/19
16:53
10/19/18
16:53
Conference/Events
Mirati Therapeutics to hold a conference call »

Dr. Charles Baum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

SPNE

SeaSpine

$16.58

-0.54 (-3.15%)

16:47
10/19/18
10/19
16:47
10/19/18
16:47
Hot Stocks
Breaking Hot Stocks news story on SeaSpine »

First Light Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$8.76

-0.04 (-0.45%)

16:46
10/19/18
10/19
16:46
10/19/18
16:46
Conference/Events
Epizyme to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

EWI

MSCI Italy Index

$25.52

0.38 (1.51%)

, SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

16:40
10/19/18
10/19
16:40
10/19/18
16:40
General news
Breaking General news story on MSCI Italy Index, SPDR S&P 500 ETF Trust, S&P 500 »

Moody's cuts Italy…

EWI

MSCI Italy Index

$25.52

0.38 (1.51%)

SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTC

Astrotech

$2.93

-0.02 (-0.68%)

16:39
10/19/18
10/19
16:39
10/19/18
16:39
Hot Stocks
Breaking Hot Stocks news story on Astrotech »

Winn Interests reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$15.43

-1.075 (-6.52%)

16:38
10/19/18
10/19
16:38
10/19/18
16:38
Conference/Events
CytomX Therapeutics to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

ICLK

iClick Interactive Asia

$3.41

(0.00%)

16:36
10/19/18
10/19
16:36
10/19/18
16:36
Hot Stocks
Breaking Hot Stocks news story on iClick Interactive Asia »

LIM Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.